The collaboration will promote Osteopore’s off-the-shelf products in Singapore for bone loss treatments in upper and lower extremities.

Anika plans to focus on its core hyaluronic acid technology and advance its differentiated Regenerative Solutions portfolio.

Patrick Beyer, current Chief Operating Officer of CONMED, will succeed the retiring Curt R. Hartman as President and CEO.

Biomendex is continuing development of its fully synthetic biodegradable Adaptos bone graft material to enable better outcomes for patients and surgeons.

The company started the sale process through voluntary court-supervised restructuring, helping to resolve legal liabilities and enter the next chapter of innovation.

Selling to ASCs requires an understanding of facility needs, surgeon preferences and how those match the operating efficiencies you can provide.

The exclusive agreement supports distribution of Novastep’s foot and ankle products across the UK, Ireland and Nordic regions.

JointVue’s patented OrthoSonic 3D Surgery Planning Technology is reportedly the only ultrasound device on the market to deliver 3D preoperative planning.

The collaboration enables distribution of OssiGraft™ and OssiGraft Prime cryopreserved viable bone matrix allografts through Enovis’ sales network.

There is opportunity for orthopedic companies to create partnerships with surgeons, department leadership and executive administration. Three leaders share how.